Current drugs acting on Toll-like receptors in the treatment of inflammatory dermatoses M.A. iONESCU

Abstract

The article presents the results of a study of the oil-in-water emulsion comprising TLR2-regul®, a complex patented by Uriage Laboratories. At the first stage of the study, skin explants from healthy donors were incubated in the physiological salt solution, oil-in-water indifferent cream excipient, with monoclonal anti-TLR2 antibodies and with the oil-in-water study emulsion, and then samples in each groups were divided into three sub-groups and incubated with extracts of M. furfur, p. acnes и S. aureus. The immune-enzyme assay method demonstrated a significant reduction in the production of IL-8 and higher quantity of β-defensin 2 in case of incubation with the study emulsion vs. the control group. At the second stage, the authors assessed the efficiency of the study emulsion in the treatment of patients suffering from seborrheic dermatitis (n = 143), acne (n = 34) and atopic dermatitis (n = 48) as a monotherapy vs. the cream base. After four weeks, patients with seborrheic dermatitis had a considerable reduction of erythema, peeling, itching and stinging, reduction in the number of recurrences; after three months, the group of acne patients had a considerably reduced number of inflammatory elements; after three weeks of treatment, patients with atopic dermatitis had a considerable reduction of erythema, infiltration and exudation as well as itching and shrinking. Thus, the study drug suggests new approaches to the treatment of inflammatory skin diseases with the pathogenesis complicated by P. acne, S. aureus or M. furfur due to its ability to modulate the immune response.

Full Text

Современные средства, воздействующие на Тоll-подобные рецепторы, в лечении воспалительных дерматозов
×

About the authors

M A lonescu

Hopital Saint-Louis

Email: dr.toni.ionescu@gmail.com
M.D., dermatologist. Polyclinique de dermatologie. Paris, France

References

  1. Kang S.S., Kauls L.S., Gaspari A.A. Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol 2006; 54(6): 951—83.
  2. Musette P., Auquit Auckbur I., Begon E. Innate immunity: cutaneous expression of Tolllike receptors. Medecine/Science, 2006; 22: 149—52.
  3. Meyer T., Stockfleth E., Christophers E. Immune response profiles in human skin. Br J Dermatol, 2007; 157(supp): 1—7.
  4. Wang X., Bi Z., Wang Y., Wang Y. Increased MAPK and NF-kB expression of Langerhans cells is dependent on TLR2 and TLR4, and increased IRF-3 expression is partially dependent on TLR4 following UV exposure. Mol Med Report., 2011; 4(3): 541—6.
  5. Hänsel A., Günther C., Ingwersen J., Starke J., Schmitz M., Bachmann M., Meurer M., Rieber E.P., Schäkel K. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. J Allergy Clin Immunol., 2011 Mar; 127(3): 787—94.
  6. O'Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., Kagnoff M.F. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163: 6718—24. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem, 1999; 274: 17406—9.
  7. Yang R.B., Mark M.R., Gurney A.L., Godowski P.J. Signaling events induced by lipopolysaccharide-αctivated toll-like receptor 2. J Immunol, 1999; 163: 639—43.
  8. Nagy I., Pivarcsi A., Koreck A., Széll M., Urban E., Kemény L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol 2005; 124: 931—8.
  9. Liu P.T., Krutzik S.R., Kim J., Modlin R.L. Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol, 2005; 174: 2467—70.
  10. Kurokawa I., Danby F.W., Ju Q., Wang X., Xiang L.F., Xia L., Chen W., Nagy I., Picardo M., Suh D.H., Ganceviciene R., Schagen S., Tsatsou F., Zouboulis C.C. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol., 2009; 18(10): 821—32.
  11. Bellew S., Thiboutot D., Del Rosso J.Q. Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. J Drugs Dermatol., 2011; 10(6): 582—5.
  12. Leyden J.J., Marples R.R., Kligman A.M. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol, 1974; 90: 525—30.
  13. Giustizieri M.L., Mascia F., Frezzolini A., De Pità O., Chinni L.M., Giannetti A., Girolomoni G., Pastore S.J. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. Allergy Clin Immunol, 2001; 107: 871—7.
  14. Cho S.H., Strickland I., Tomkinson A., Fehringer A.P., Gelfand E.W., Leung D.Y. Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. J Invest Dermatol, 2001; 116: 658—63.
  15. Harder J., Bartels J., Christophers E., Schröder J.M. A peptide antibiotic from human skin. Nature, 1997; 387 (6636): 861.
  16. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem, 1999; 274: 17406—9.
  17. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med, 2002; 347: 1151—60.
  18. Niebuhr M., Heratizadeh A., Wichmann K., Satzger I., Werfel T. Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients. Exp Dermatol., 2011; 20(6): 468—72.
  19. Baroni A., Orlando M., Donnarumma G., Farro P., Iovene M.R., Tufano M.A., Buommino E. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res., 2006 Jan; 297(7): 280—8.
  20. Dreno B., Alirezai M., Auffret N., Beylot C., Chivot M., Daniel F., Faure M., Lambert D., Poli F., Merial-Kieny C., Nocera T. Clinical and psychological correlation in acne: use of the ECLA and CADI scales. Ann Dermatol, 2007; 134: 451—5.
  21. Ionescu M.A., Baroni A., Brambilla L., Cannavo S.P., Cristaudo A., Vedove C.D., Frasca M., Girolomoni G., Gnecchi L., Peris K., Trifiro C., Matta A.M., Robert G. Double blind clinical trial in a series of 115 patients with seborrheic dermatitis: prevention of relapses using a topical modulator of Toll like receptor 2. G Ital Dermatol Venereol, 2011; 146: 185—9.

Statistics

Views

Abstract: 693

PDF (Russian): 384

Article Metrics

Metrics Loading ...

Dimensions

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2012 lonescu M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies